Craft

Legend Biotech

Stock Price

$45.5

2024-10-29

Market Capitalization

$8.4 B

2024-10-29

Revenue

$1 B

FY, 2025

Legend Biotech Summary

Company Summary

Overview
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. It also provides research and development, cell clinical studies, therapy, and other services.
Type
Public
Status
Active
Founded
2014
HQ
Somerset, NJ, US | view all locations
Website
https://legendbiotech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Ying Huang

    Ying Huang, Chief Executive Officer, Director

  • Lori MacOmber

    Lori MacOmber, Chief Financial Officer

  • Guowei Fang

    Guowei Fang, Chief Scientific Officer and Head of Business Development

  • Mythili Koneru

    Mythili Koneru, Chief Medical Officer

LocationsView all

6 locations detected

  • Somerset, NJ HQ

    United States

    2101 Cottontail Lane

  • Piscataway, NJ

    United States

    10 Knightsbridge Road

  • Ghent, Vlaams Gewest

    Belgium

    Technologiepark 122

  • Nanjing

    China

    No. 6 Building, Life Science TechTown, 568 Longmian Avenue

  • Hong Kong, Hong Kong Island

    Hong Kong

    The Hong Kong Club Building, 3A Chater Rd

  • Dublin, County Dublin

    Ireland

    10A Ballymoss Road, Sandyford Business Park

Legend Biotech Financials

Summary Financials

Revenue (FY, 2025)
$1.0B
Gross profit (FY, 2025)
$620.8M
Net income (FY, 2025)
($296.8M)
Cash (FY, 2025)
$901.9M
EBIT (FY, 2025)
($136.5M)
Enterprise value
$7.9B

Footer menu